Evidence-first development

Research & Validation

We publish our methods, share our datasets and submit every model to rigorous external validation before it reaches a patient.

95%

Classification accuracy · ISIC held-out validation

±0.18 mm

Depth MAE · Breslow regression

140+

Skin conditions recognised from phone photo

12

Peer-reviewed publications in submission

Validation pipeline

Four phases from lab bench to bedside. No shortcuts.

Phase 01Complete

Internal validation

Stratified k-fold cross-validation on ISIC 2016–2024, HAM10000 and our proprietary DermaPrime Atlas. Class-balanced sampling and demographic parity checks.

Phase 02In progress

External validation

Independent test sets from Cracow Medical Hospitals and Stanford Dermatology. Images captured on different devices, by different operators, in different lighting.

Phase 03Recruiting

Prospective clinical study

A multi-centre, prospective reader study comparing DermaPrime against board-certified dermatologists on consecutive real-world patient images. Primary endpoint: sensitivity & specificity.

Phase 04In preparation

Regulatory submission

CE-IVDR technical documentation and FDA 510(k) pre-submission meetings. Expected regulatory clearance timeline: Q4 2026.

Peer-reviewed research

Selected melanoma & dermoscopy publications by our CEO and scientific lead, Prof. Joanna Jaworek-Korjakowska, and collaborators. Full bibliography on Google Scholar.

Data transparency

We test on public datasets, but we train on our own datasets. Our models are trained on a carefully curated mix of public dermatology archives and proprietary clinical datasets. We disclose provenance, bias audits and exclusion criteria.

  • ISIC Archive (2016–2024) — 400,000+ dermoscopic images
  • HAM10000 — 10,015 dermatoscopic images of common pigmented lesions
  • DermaPrime Atlas — 50,000+ smartphone & dermoscope images with histopathology correlation
  • Annual bias audits by independent epidemiologists
  • Demographic parity checks across Fitzpatrick skin types I–VI

Ethical data pledge

We never purchase scraped or unconsented medical images. Every image in the DermaPrime Atlas was captured with informed consent, anonymised at source, and is governed by a Data Processing Agreement aligned with GDPR and HIPAA.

We publish annual transparency reports on model performance across skin-tone groups, age bands and anatomic sites.

Independent review: Our data governance framework was reviewed and endorsed by the Oxford Internet Institute Ethics Board in 2024.

Interested in collaborating?

We are open to academic partnerships, multi-centre studies and independent model audits.